drugset
drugset / Trial / NCT03771105

The Impact of Phosphate Metabolism on Healthy Aging

NCT03771105 ↗

Phase 0 Recruiting 30 enrolled Yale University National Center for Advancing Translational Sciences (NCATS) · collab
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial function), and cardiovascular function (echo- cardiography) in patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH) and patients with X-linked hypophosphatemia (XLH).

Timeline

Start
2019-01-01
Primary completion
2028-04
Completion
2028-04

Drugs

EvaluationDrugModalityDoseRoute
Subject phosphate Unknown 3500 mg —

Indications

X-linked hypophosphatemic rickets hereditary hypophosphatemic rickets with hypercalciuria hypophosphatemia idiopathic hypercalciuria